ClinConnect ClinConnect Logo
Search / Trial NCT02327780

The Effectivness of FODMAP Diet in Israel in Relieving Symptoms of Patients With Irritable Bowel Syndrome

Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Dec 29, 2014

Trial Information

Current as of June 30, 2025

Unknown status

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Fulfillment of the Rome III criteria for IBS.
  • 2. Aged 18-77 years at the time of screening.
  • 3. Provision of written informed consent.
  • 4. Commitment of availability throughout the 10 week study period.
  • 5. Availability of at least one GI imaging study during the last 5 years (colonoscopy, sigmoidosopy, abdominal ultrasonography, barium enema) for subjects older than 50 years.
  • Exclusion Criteria:
  • 1. Major abdominal surgery in the past.
  • 2. The presence of any active (organic) GI disease.
  • 3. Past or present major medical or psychiatric illness.
  • 4. Any concomitant disease.
  • 5. Alarming symptoms (rectal bleeding, weight loss, etc.)
  • 6. Pregnancy.
  • 7. Family history of colorectal carcinoma or IBD, under the age of 50.
  • 8. Abnormal laboratory studies (blood biochemistry, liver enzymes, complete blood count), abnormal thyroid function.
  • 9. Non-adjusted diet in the case of lactose or gluten intolerance.
  • 10. Recent travel to regions with endemic parasitic diseases.

About Tel Aviv Sourasky Medical Center

Tel Aviv Sourasky Medical Center, a leading academic medical institution in Israel, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a multidisciplinary approach, the center integrates cutting-edge medical technology and evidence-based practices to enhance patient care and outcomes. Its robust infrastructure supports a diverse range of clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. The center's dedication to research excellence and patient safety positions it as a key player in the global clinical research landscape, driving advancements in medical knowledge and treatment options.

Locations

Tel Aviv, , Israel

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials